Fără conexiune la internet — se afișează versiunea salvată a paginii.

Merck KGaA ADR

USUSD
← Către filtru

Merck KGaA ADR (LSE:0QAH) — Biotechnology: Pharmaceutical Preparations. Numărul de burse pe care se tranzacționează acțiunile companiei: 6. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.

⚠ Nu le amesteca: există o altă companie cu același nume sau unul foarte asemănător. Este o înregistrare separată — verifică tickerul, numărul de schimb și numărul de înregistrare.
  • Merck KGaA — MRK · XETRA DE Număr de înregistrare necunoscut

Despre companie

Site web
merck.com
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sediu central
RAHWAY, Germany
Director general
Kai Beckmann
Angajați
62 136
Acțiuni în circulație
2.47 mld. la 2026-07-31
Free float
644.35 mil.
Capitalizare de piață
67.93 mld. USD
Insideri
0%
Investitori instituționali
0.02%
Industrie (SIC)
Pharmaceutical Preparations
Formă juridică
XSNP
ISIN
US58933Y1055
LEI
4YV9Y5M8S0BRK1RP0397
Rata de distribuire
262%
FCF
16.1 mld. USD
52%
Datorie
51.1 mld. USD
2.8 ani FCF
Vechimea dividendelor
56+ ani
Câștiguri, FCF și dividende plătite — pentru cele 12 luni până la 30.06.2026 (cel mai recent raport al companiei).
Descriere

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Burse și simboluri

BursăSimbolMonedăPrețTip
US USA StocksMRK secundarăUSD142.38 -0.29%acțiuni ordinare
LSE London Stock Exchange0QAH IOBUSD148.65 -0.12%acțiuni ordinare
MI Borsa Italiana (Milan)1MRKX principalăEUR129.56 +3.96%acțiuni ordinare
MX Mexican Stock ExchangeMRK secundarăMXN2 561 +0.91%acțiuni ordinare
VI Vienna Stock ExchangeMRK secundarăEUR124.84 -2.79%acțiuni ordinare
XETRA Xetra6MK secundarăEUR129.78 +0.09%acțiuni ordinare

Preț pe 3 luni

zi de creștere zi de scădere data ex-dividend data plățiiTreceți cu mouse-ul / atingeți o zi — prețurile de deschidere, închidere, maxim și minim

Dividende

Ultimele 12 luni, LSE:0QAH: 3.4 USD (4 plăți)

Merck KGaA ADR (0QAH) plătește dividende trimestrial. În ultimele 12 luni, s-au plătit 3.4 USD pe acțiune (plăți: 4). Aceasta reprezintă aproximativ 2.29% din prețul actual al acțiunilor. Pe baza istoricului plăților, următoarea dată ex-dividend este așteptată în jurul datei de 15.12.2026. Istoric neîntrerupt al dividendelor: 56 ani.

Data exPlatăSumă%TipSimbol
2026-09-152026-10-070.8500 USD0.6/2.3 %trimestrialLSE:0QAH
2026-06-152026-07-080.8500 USD0.6/2.3 %trimestrialLSE:0QAH
2026-03-162026-04-070.8500 USD0.6/2.2 %trimestrialLSE:0QAH
2025-12-152026-01-080.8500 USD0.6/2.2 %trimestrialLSE:0QAH
2025-09-152025-10-070.8100 USD0.5/2.2 %trimestrialLSE:0QAH
2025-06-162025-07-080.8100 USD0.5/2.2 %trimestrialLSE:0QAH
2025-03-172025-04-070.8100 USD0.5/2.1 %trimestrialLSE:0QAH
2024-12-16—0.8100 USD0.5/2.1 %trimestrialLSE:0QAH
2024-09-16—0.7700 USD0.5/2.1 %trimestrialLSE:0QAH
2024-06-17—0.7700 USD0.5/2.0 %trimestrialLSE:0QAH
2024-03-14—0.7700 USD0.5/2.0 %trimestrialLSE:0QAH
2023-12-14—0.7700 USD0.5/2.0 %trimestrialLSE:0QAH
2023-09-14—0.7300 USD0.5/2.0 %trimestrialLSE:0QAH
2023-06-14—0.7300 USD0.5/1.9 %trimestrialLSE:0QAH
2023-03-14—0.7300 USD0.5/1.9 %trimestrialLSE:0QAH
2022-12-14—0.7300 USD0.5/1.9 %trimestrialLSE:0QAH
2022-09-14—0.6900 USD0.5/1.9 %trimestrialLSE:0QAH
2022-06-14—0.6900 USD0.5/1.4 %trimestrialLSE:0QAH
2022-03-14—0.6900 USD0.5/0.9 %trimestrialLSE:0QAH
2021-12-14—0.6900 USD0.5/0.5 %trimestrialLSE:0QAH

Știri din această săptămână

Încă nu există știri de pe site-ul companiei.

publicitate

Cei mai mari acționari

DeținătorParticipațieAcțiuniData raportului
BlackRock9.2%227 mil.2026-06-30
Vanguard Capital Managem…6.54%161.32 mil.2026-06-30
State Street Corporation4.88%120.41 mil.2026-06-30
Wellington Management Gr…3.5%86.25 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%78.41 mil.2026-06-30
Vanguard Portfolio Manag…2.75%67.74 mil.2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%64 mil.2026-06-30
Geode Capital Management…2.46%60.74 mil.2026-06-30
Charles Schwab Investmen…2.2%54.37 mil.2026-06-30
Morgan Stanley1.97%48.64 mil.2026-06-30
FMR, LLC1.84%45.44 mil.2026-06-30
JPMORGAN CHASE & CO1.78%43.89 mil.2026-06-30
iShares Trust-iShares Co…1.33%32.89 mil.2026-08-31
Fidelity Concord Street…1.29%31.94 mil.2026-07-31
SCHWAB STRATEGIC TRUST-S…1.25%30.86 mil.2026-05-31
SPDR S&P 500 ETF TRUST-S…1.22%30.22 mil.2026-08-31
VANGUARD INDEX FUNDS-Van…0.95%23.51 mil.2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%17.75 mil.2026-08-31
VANGUARD SPECIALIZED FUN…0.65%15.95 mil.2026-07-31
VANGUARD SPECIALIZED FUN…0.57%13.97 mil.2026-07-31
DAVIS ROBERT M (Chief Ex…≈0.02%450 3512026-04-29
CHATTOPADHYAY SANAT (Off…≈0.01%200 6752026-04-29
DELUCA RICHARD ROBERT JR…≈0%110 1672026-08-12
LI DEAN Y (Officer)≈0%94 4312026-04-29
LITCHFIELD CAROLINE (Chi…≈0%92 3002026-04-29
ZACHARY JENNIFER L (Gene…≈0%45 5092026-08-12
GUINDO CHIRFI (Officer)≈0%36 6132026-08-13
WILLIAMS DAVID MICHAEL (…≈0%31 7162026-08-05
ROMANELLI JOSEPH EDWARD…≈0%28 7392026-01-26
OOSTHUIZEN JOHANNES JACO…≈0%21 8952026-04-29
Trust for Professional M…0%24 8032026-05-31
Rhumbline Advisers0%10 9192026-06-30
SP Funds Trust-SP Funds…0%6 5422026-07-31
Atlas Capital Advisors I…0%2 4672026-06-30
Gamma Investing LLC0%2 3022026-06-30
Salomon & Ludwin, LLC0%3562026-06-30
PNC Financial Services G…0%22026-06-30
The Vanguard Group———